K‑CAB® (Tegoprazan)
Gastro‑esophageal reflux disease
Commercial (licensed)Active
Key Facts
Indication
Gastro‑esophageal reflux disease
Phase
Commercial (licensed)
Status
Active
Company
About Tabuk Pharmaceuticals
Leading MENA generic drug maker expanding into specialty oncology through strategic partnerships.
View full company profile